TrialAnnals of hematology2021
Phase II study of single-agent nivolumab in patients with myelofibrosis.
Iman Abou Dalle et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
TrialAnnals of hematology2021
Iman Abou Dalle et al.PubMed ↗Publisher ↗
No numbers read from the abstract.